Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prospective comparison of [18F]AlF-NOTA-octreotide PET/MRI to [68Ga]Ga-DOTATATE PET/CT in neuroendocrine tumor patients.
Boeckxstaens L, Pauwels E, Vandecaveye V, Deckers W, Cleeren F, Dekervel J, Vandamme T, Serdons K, Koole M, Bormans G, Laenen A, Clement PM, Geboes K, Van Cutsem E, Nackaerts K, Stroobants S, Verslype C, Van Laere K, Deroose CM. Boeckxstaens L, et al. Among authors: cleeren f. EJNMMI Res. 2023 Jun 1;13(1):53. doi: 10.1186/s13550-023-01003-3. EJNMMI Res. 2023. PMID: 37261615 Free PMC article.
Retention of [(18)F]fluoride on reversed phase HPLC columns.
Ory D, Van den Brande J, de Groot T, Serdons K, Bex M, Declercq L, Cleeren F, Ooms M, Van Laere K, Verbruggen A, Bormans G. Ory D, et al. Among authors: cleeren f. J Pharm Biomed Anal. 2015;111:209-14. doi: 10.1016/j.jpba.2015.04.009. Epub 2015 Apr 9. J Pharm Biomed Anal. 2015. PMID: 25898315
Al18F-NOTA-octreotide: first comparison with 68Ga-DOTATATE in a neuroendocrine tumour patient.
Pauwels E, Cleeren F, Tshibangu T, Koole M, Serdons K, Dekervel J, Van Cutsem E, Verslype C, Van Laere K, Bormans G, Deroose CM. Pauwels E, et al. Among authors: cleeren f. Eur J Nucl Med Mol Imaging. 2019 Oct;46(11):2398-2399. doi: 10.1007/s00259-019-04425-1. Epub 2019 Jul 31. Eur J Nucl Med Mol Imaging. 2019. PMID: 31367905 No abstract available.
Design and Challenges of Radiopharmaceuticals.
Vermeulen K, Vandamme M, Bormans G, Cleeren F. Vermeulen K, et al. Among authors: cleeren f. Semin Nucl Med. 2019 Sep;49(5):339-356. doi: 10.1053/j.semnuclmed.2019.07.001. Epub 2019 Jul 20. Semin Nucl Med. 2019. PMID: 31470930 Review.
35 results